Microwave Ablation

What is Microwave Ablation (MWA)?

Microwave ablation is an advanced thermal ablation modality primarily utilized to induce coagulative necrosis (destruction) of targeted neoplastic tissues, such as malignant tumors.

How Does It Work?

• Procedural Access: The procedure is typically performed under local anesthesia or conscious sedation. Utilizing real-time imaging guidance (such as ultrasound, CT, or MRI), a specialized, thin microwave antenna (probe) is percutaneously advanced directly into the core of the target lesion.
• Microwave Energy Delivery: High-frequency electromagnetic microwave energy is transmitted through the antenna into the surrounding tissue.
• Thermal Tissue Destruction: This electromagnetic field causes continuous rotation of water molecules within the tissue, rapidly generating frictional hyperthermia. As the intra-tumoral temperature rises, it induces cellular dehydration, protein denaturation, and immediate coagulative necrosis, effectively destroying the pathological tissue.

Clinical Advantages of MWA

• Minimally Invasive Profile: It represents a significantly less invasive alternative to open surgical resection, resulting in reduced surgical trauma and a shorter hospital length of stay.
• Accelerated Recovery: The post-procedural healing timeline is brief, allowing patients to resume their standard activities of daily living within a short period.
• High Therapeutic Efficacy: It yields exceptional local tumor control and success rates, particularly in small, localized, non-metastatic tumors.

Clinical Indications and Fields of Use

Microwave ablation is widely utilized as a primary or alternative interventional oncological therapy for solid tumors located in organs such as the liver (hepatocellular carcinoma and colorectal metastases), kidneys (renal cell carcinoma), and lungs.

Ultimately, the decision to undergo microwave ablation must be strictly evaluated and custom-tailored by a multidisciplinary oncology board in accordance with the patient’s specific clinical status, tumor staging, and anatomical eligibility.